About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Hyperphosphatemia in Children With Chronic Kidney Disease

NCT03202407·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Amed roshdy, professor
CONTACT
01001998013 ahmedroshdy2@hotmail.com

Lead

Assiut University

Age

6–18

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Children aged from 6 to 18 years
With end stage renal disease on regular hemodialysis,
With hyperphosphatemia (serum phosphorus \> 4.5mg/dL ).
Both genders will be included
Given informed concent.

You may not be if

\- Children \< 6 years,
Severe Gastrointestinal disorder,
Known hypersensitivity to phosphate binders,
Inability or rejection to give informed consent,
Normal serum phosphate level.

The record

StatusUnknown

PhasePhase 3

Taking part40

StartedAug 2017

UpdatedJun 28, 2017

Conditions

Hyperphosphatemia

Clareo Health | Hyperphosphatemia in Children With Chronic Kidney Disease